A novel, disruptive vaccination technology: self-adjuvanted RNActive(®) vaccines.
Saved in:
| Title: | A novel, disruptive vaccination technology: self-adjuvanted RNActive(®) vaccines. |
|---|---|
| Authors: | Kallen KJ; CureVac GmbH; Tübingen, Germany., Heidenreich R; CureVac GmbH; Tübingen, Germany., Schnee M; CureVac GmbH; Tübingen, Germany., Petsch B; CureVac GmbH; Tübingen, Germany., Schlake T; CureVac GmbH; Tübingen, Germany., Thess A; CureVac GmbH; Tübingen, Germany., Baumhof P; CureVac GmbH; Tübingen, Germany., Scheel B; CureVac GmbH; Tübingen, Germany., Koch SD; CureVac GmbH; Tübingen, Germany., Fotin-Mleczek M; CureVac GmbH; Tübingen, Germany. |
| Source: | Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2013 Oct; Vol. 9 (10), pp. 2263-76. Date of Electronic Publication: 2013 Jun 04. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2164-554X |
|---|---|
| DOI: | 10.4161/hv.25181 |
